Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da Universidade Federal do Ceará (UFC) |
Texto Completo: | http://www.repositorio.ufc.br/handle/riufc/9453 |
Resumo: | Histoplasmosis is a severe infection that affects millions of patients worldwide and is endemic in the Americas. Amphotericin B (AMB) and itraconazole are highly effective for the treatment of severe and milder forms of the disease, but AMB is toxic, and the bioavailability of itraconazole is erratic. Therefore, it is important to investigate new classes of drugs for histoplasmosis treatment. In this study, a series of nine isoniazid hydrazone derivatives were synthesized and evaluated for their antifungal activities in vitro against the dimorphic fungus Histoplasma capsulatum var. capsulatum. The drugs were tested by microdilution in accordance with CLSI guidelines. The compound N=-(1-phenylethylidene)isonicotinohydrazide had the lowest MIC range of all the compounds for the yeast and filamentous forms of H. capsulatum. The in vitro synergy of this compound with AMB against the planktonic and biofilm forms of H. capsulatum cells was assessed by the checkerboard method. The effects of this hydrazone on cellular ergosterol content and membrane integrity were also investigated. The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus. Furthermore, the compound alone or in combination with AMB showed inhibitory effects against mature biofilms of H. capsulatum. N=-(1-Phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis. |
id |
UFC-7_4a900b25f6518c4bc3b140263bea0b39 |
---|---|
oai_identifier_str |
oai:repositorio.ufc.br:riufc/9453 |
network_acronym_str |
UFC-7 |
network_name_str |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
repository_id_str |
|
spelling |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatumHistoplasmaAnfotericina BHistoplasmosis is a severe infection that affects millions of patients worldwide and is endemic in the Americas. Amphotericin B (AMB) and itraconazole are highly effective for the treatment of severe and milder forms of the disease, but AMB is toxic, and the bioavailability of itraconazole is erratic. Therefore, it is important to investigate new classes of drugs for histoplasmosis treatment. In this study, a series of nine isoniazid hydrazone derivatives were synthesized and evaluated for their antifungal activities in vitro against the dimorphic fungus Histoplasma capsulatum var. capsulatum. The drugs were tested by microdilution in accordance with CLSI guidelines. The compound N=-(1-phenylethylidene)isonicotinohydrazide had the lowest MIC range of all the compounds for the yeast and filamentous forms of H. capsulatum. The in vitro synergy of this compound with AMB against the planktonic and biofilm forms of H. capsulatum cells was assessed by the checkerboard method. The effects of this hydrazone on cellular ergosterol content and membrane integrity were also investigated. The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus. Furthermore, the compound alone or in combination with AMB showed inhibitory effects against mature biofilms of H. capsulatum. N=-(1-Phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis.Antimicrobial Agents and Chemotherapy2014-10-15T11:55:10Z2014-10-15T11:55:10Z2014-05info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfCORDEIRO, R. A. et al. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, Bethesda, v. 58, n. 5, p. 2504-2511, maio, 2014.0066-4804 Impresso1098-6596 On linehttp://www.repositorio.ufc.br/handle/riufc/9453Cordeiro, Rossana de AguiarMarques, Francisca Jakelyne de FariasCordeiro, Rebecca de AguiarSilva, Marcos Reinaldo daMalaquias, Angela Donato MaiaMelo, Charlline Vládia Silva deMafezoli, JairOliveira, Maria da Conceição Ferreira deBrilhante, Raimunda Sâmia NogueiraRocha, Marcos Fábio GadelhaBandeira, Tereza de Jesus Pinheiro GomesSidrim, José Júlio Costaengreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccess2021-03-30T13:25:30Zoai:repositorio.ufc.br:riufc/9453Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2024-09-11T19:00:51.342477Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false |
dc.title.none.fl_str_mv |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
title |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
spellingShingle |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum Cordeiro, Rossana de Aguiar Histoplasma Anfotericina B |
title_short |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
title_full |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
title_fullStr |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
title_full_unstemmed |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
title_sort |
Synthesis and antifungal activity In vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum |
author |
Cordeiro, Rossana de Aguiar |
author_facet |
Cordeiro, Rossana de Aguiar Marques, Francisca Jakelyne de Farias Cordeiro, Rebecca de Aguiar Silva, Marcos Reinaldo da Malaquias, Angela Donato Maia Melo, Charlline Vládia Silva de Mafezoli, Jair Oliveira, Maria da Conceição Ferreira de Brilhante, Raimunda Sâmia Nogueira Rocha, Marcos Fábio Gadelha Bandeira, Tereza de Jesus Pinheiro Gomes Sidrim, José Júlio Costa |
author_role |
author |
author2 |
Marques, Francisca Jakelyne de Farias Cordeiro, Rebecca de Aguiar Silva, Marcos Reinaldo da Malaquias, Angela Donato Maia Melo, Charlline Vládia Silva de Mafezoli, Jair Oliveira, Maria da Conceição Ferreira de Brilhante, Raimunda Sâmia Nogueira Rocha, Marcos Fábio Gadelha Bandeira, Tereza de Jesus Pinheiro Gomes Sidrim, José Júlio Costa |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Cordeiro, Rossana de Aguiar Marques, Francisca Jakelyne de Farias Cordeiro, Rebecca de Aguiar Silva, Marcos Reinaldo da Malaquias, Angela Donato Maia Melo, Charlline Vládia Silva de Mafezoli, Jair Oliveira, Maria da Conceição Ferreira de Brilhante, Raimunda Sâmia Nogueira Rocha, Marcos Fábio Gadelha Bandeira, Tereza de Jesus Pinheiro Gomes Sidrim, José Júlio Costa |
dc.subject.por.fl_str_mv |
Histoplasma Anfotericina B |
topic |
Histoplasma Anfotericina B |
description |
Histoplasmosis is a severe infection that affects millions of patients worldwide and is endemic in the Americas. Amphotericin B (AMB) and itraconazole are highly effective for the treatment of severe and milder forms of the disease, but AMB is toxic, and the bioavailability of itraconazole is erratic. Therefore, it is important to investigate new classes of drugs for histoplasmosis treatment. In this study, a series of nine isoniazid hydrazone derivatives were synthesized and evaluated for their antifungal activities in vitro against the dimorphic fungus Histoplasma capsulatum var. capsulatum. The drugs were tested by microdilution in accordance with CLSI guidelines. The compound N=-(1-phenylethylidene)isonicotinohydrazide had the lowest MIC range of all the compounds for the yeast and filamentous forms of H. capsulatum. The in vitro synergy of this compound with AMB against the planktonic and biofilm forms of H. capsulatum cells was assessed by the checkerboard method. The effects of this hydrazone on cellular ergosterol content and membrane integrity were also investigated. The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus. Furthermore, the compound alone or in combination with AMB showed inhibitory effects against mature biofilms of H. capsulatum. N=-(1-Phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-10-15T11:55:10Z 2014-10-15T11:55:10Z 2014-05 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
CORDEIRO, R. A. et al. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, Bethesda, v. 58, n. 5, p. 2504-2511, maio, 2014. 0066-4804 Impresso 1098-6596 On line http://www.repositorio.ufc.br/handle/riufc/9453 |
identifier_str_mv |
CORDEIRO, R. A. et al. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, Bethesda, v. 58, n. 5, p. 2504-2511, maio, 2014. 0066-4804 Impresso 1098-6596 On line |
url |
http://www.repositorio.ufc.br/handle/riufc/9453 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Antimicrobial Agents and Chemotherapy |
publisher.none.fl_str_mv |
Antimicrobial Agents and Chemotherapy |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da Universidade Federal do Ceará (UFC) instname:Universidade Federal do Ceará (UFC) instacron:UFC |
instname_str |
Universidade Federal do Ceará (UFC) |
instacron_str |
UFC |
institution |
UFC |
reponame_str |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
collection |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
repository.name.fl_str_mv |
Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC) |
repository.mail.fl_str_mv |
bu@ufc.br || repositorio@ufc.br |
_version_ |
1813029033755017216 |